Scaling and sustaining COVID-19 vaccination through meaningful community engagement and care coordination for underserved communities: hybrid type 3 effectiveness-implementation sequential multiple assignment randomized trial.
Scaling and sustaining COVID-19 vaccination through meaningful community engagement and care coordination for underserved communities: hybrid type 3 effectiveness-implementation sequential multiple assignment randomized trial.
复制标题
DOI：
10.1186/s13012-023-01283-2
复制
发表时间：
2023-07-14
影响因子：
7.2
通讯作者：
Stadnick, Nicole A. A.
中科院分区：
文献类型：
--
作者：
Rabin, Borsika A. A.;Cain, Kelli L. L.;Watson Jr, Paul;Oswald, William;Laurent, Louise C. C.;Meadows, Audra R. R.;Seifert, Marva;Munoz, Fatima A. A.;Salgin, Linda;Aldous, Jeannette;Diaz, Edgar A. A.;Villodas, Miguel;Vijaykumar, Santosh;O'Leary, Sean T. T.;Stadnick, Nicole A. A.
关键词：
COVID-19的不平等在低收入的有色人种社区比比皆是。应对COVID-19疫苗犹豫，以促进为服务不足的社区提供公平和持续的疫苗接种，需要采取多层次、可扩展和可持续的方法。同样重要的是，努力承认这些社区更广泛的医疗保健需求，包括参与预防服务。这是一项混合型3有效性-实施研究，将包括多层次、纵向、混合方法的数据收集方法，旨在评估共同创建的多组分战略的持续影响，该战略依赖于所有团队成员的双向学习、共享决策和专业知识。该研究利用了实施战略的组合，包括mHealth外展与文化上适当的信息传递，护理协调，以增加对高度优先预防服务的参与，以及使用社区编织者领导的社区咨询委员会共同设计这些战略。社区编织者是作为服务不足的社区成员的个人，作为社区，公共卫生系统和研究人员之间的文化经纪人，共同创造社区驱动的，文化敏感的公共卫生解决方案。本研究将采用一种适应性实施方法，在一项序贯多分配随机试验设计中进行操作，该试验设计包括来自南加州一家联邦合格健康中心三个研究中心的300名参与者。这一设计将使人们能够审查执行战略各组成部分的影响，并向受益最多的人提供更密集的支持。主要有效性成果为COVID-19疫苗完成、参与预防服务及疫苗信心。主要的实施成果是在12个月的随访期内达到、采用、实施和维持多部分战略。混合效应逻辑回归模型将用于检查计划的影响，并将与参与者和实施者的定性数据进行三角测量。这项研究利用社区参与，实施科学，健康公平和沟通，传染病和公共卫生的观点，共同创建一个多方面的战略，以促进圣地亚哥服务不足社区的COVID-19疫苗接种和预防服务的吸收。研究设计强调我们的社区和诊所合作伙伴的广泛参与，导致文化敏感和可接受的战略，以产生疫苗公平和预防服务参与的持久和可持续的增长。ClinicalTrials.gov标识符：NCT 05841810 2023年5月3日
COVID-19 inequities are abundant in low-income communities of color. Addressing COVID-19 vaccine hesitancy to promote equitable and sustained vaccination for underserved communities requires a multi-level, scalable, and sustainable approach. It is also essential that efforts acknowledge the broader healthcare needs of these communities including engagement in preventive services. This is a hybrid type 3 effectiveness-implementation study that will include a multi-level, longitudinal, mixed-methods data collection approach designed to assess the sustained impact of a co-created multicomponent strategy relying on bidirectional learning, shared decision-making, and expertise by all team members. The study capitalizes on a combination of implementation strategies including mHealth outreach with culturally appropriate messaging, care coordination to increase engagement in high priority preventive services, and the co-design of these strategies using community advisory boards led by Community Weavers. Community Weavers are individuals with lived experience as members of an underserved community serving as cultural brokers between communities, public health systems, and researchers to co-create community-driven, culturally sensitive public health solutions. The study will use an adaptive implementation approach operationalized in a sequential multiple assignment randomized trial design of 300 participants from three sites in a Federally Qualified Health Center in Southern California. This design will allow examining the impact of various implementation strategy components and deliver more intensive support to those who benefit from it most. The primary effectiveness outcomes are COVID-19 vaccine completion, engagement in preventive services, and vaccine confidence. The primary implementation outcomes are reach, adoption, implementation, and maintenance of the multicomponent strategy over a 12-month follow-up period. Mixed-effects logistic regression models will be used to examine program impacts and will be triangulated with qualitative data from participants and implementers. This study capitalizes on community engagement, implementation science, health equity and communication, infectious disease, and public health perspectives to co-create a multicomponent strategy to promote the uptake of COVID-19 vaccination and preventive services for underserved communities in San Diego. The study design emphasizes broad engagement of our community and clinic partners leading to culturally sensitive and acceptable strategies to produce lasting and sustainable increases in vaccine equity and preventive services engagement. ClinicalTrials.gov Identifier: NCT05841810 May 3, 2023
登录
查看更多内容
影响因子：
5.5
作者：
Daley, Matthew F.;Narwaney, Komal J.;Glanz, Jason M.
通讯作者：
Glanz, Jason M.
影响因子：
3
作者：
Curran GM;Bauer M;Mittman B;Pyne JM;Stetler C
通讯作者：
Stetler C
影响因子：
3.4
作者：
Fetters, Michael D.;Curry, Leslie A.;Creswell, John W.
通讯作者：
Creswell, John W.
影响因子：
3.6
作者：
Salgin, Linda;Ayers, Lawrence O.;Burola, Maria-Linda;Engler, Anne-Marie;Osuna, Alexis;Gay, Luis;Cain, Kelli;Stadnick, Nicole;Rabin, Borsika;Zaslavsky, Ilya;Laurent, Louise C.;Tukey, Robert;Seifert, Marva
通讯作者：
Seifert, Marva
影响因子：
11.1
作者：
Arnold, Marlen
通讯作者：
Arnold, Marlen